MRPL54
gene geneOn this page
Also known as mL54
Summary
MRPL54 (mitochondrial ribosomal protein L54, HGNC:16685) is a protein-coding gene on chromosome 19p13.3, encoding Large ribosomal subunit protein mL54 (Q6P161). It is a selective cancer dependency (DepMap: 35.8% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein.
Source: NCBI Gene 116541 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 31 total — 1 pathogenic
- Cancer dependency (DepMap): dependent in 35.8% of screened cell lines
- MANE Select transcript:
NM_172251
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16685 |
| Approved symbol | MRPL54 |
| Name | mitochondrial ribosomal protein L54 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | mL54 |
| Ensembl gene | ENSG00000183617 |
| Ensembl biotype | protein_coding |
| OMIM | 611858 |
| Entrez | 116541 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000330133, ENST00000589174, ENST00000884969, ENST00000939301
RefSeq mRNA: 1 — MANE Select: NM_172251
NM_172251
CCDS: CCDS12111
Canonical transcript exons
ENST00000330133 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001291983 | 3762682 | 3762818 |
| ENSE00001325964 | 3767261 | 3767565 |
| ENSE00001330192 | 3765166 | 3765331 |
Expression profiles
Bgee: expression breadth ubiquitous, 246 present calls, max score 97.06.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 37.5237 / max 300.4404, expressed in 1822 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173239 | 36.7084 | 1822 |
| 173240 | 0.8153 | 456 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 97.06 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.39 | gold quality |
| right lobe of liver | UBERON:0001114 | 96.32 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.28 | gold quality |
| apex of heart | UBERON:0002098 | 96.16 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.10 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.86 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.84 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.77 | gold quality |
| monocyte | CL:0000576 | 95.66 | gold quality |
| leukocyte | CL:0000738 | 95.63 | gold quality |
| body of stomach | UBERON:0001161 | 95.57 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 95.49 | gold quality |
| body of pancreas | UBERON:0001150 | 95.31 | gold quality |
| adrenal cortex | UBERON:0001235 | 95.25 | gold quality |
| pituitary gland | UBERON:0000007 | 95.00 | gold quality |
| left coronary artery | UBERON:0001626 | 94.80 | gold quality |
| adrenal gland | UBERON:0002369 | 94.66 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 94.62 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 94.62 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.61 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.51 | gold quality |
| coronary artery | UBERON:0001621 | 94.47 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.40 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.40 | gold quality |
| lower esophagus | UBERON:0013473 | 94.39 | gold quality |
| right coronary artery | UBERON:0001625 | 94.35 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 94.34 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.29 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 13.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
3 targeting MRPL54, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-1912-3P | 99.32 | 67.40 | 936 |
| HSA-MIR-1295B-5P | 99.03 | 67.50 | 810 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 35.8% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- Expression analysis of mammalian mitochondrial ribosomal protein genes (PMID:32987154)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrpl54 | ENSDARG00000071468 |
| mus_musculus | Mrpl54 | ENSMUSG00000034932 |
| rattus_norvegicus | Mrpl54 | ENSRNOG00000020464 |
| drosophila_melanogaster | mRpL54 | FBGN0034579 |
| caenorhabditis_elegans | mrpl-54 | WBGENE00009128 |
Protein
Protein identifiers
Large ribosomal subunit protein mL54 — Q6P161 (reviewed: Q6P161)
Alternative names: 39S ribosomal protein L54, mitochondrial
All UniProt accessions (2): K7ENN2, Q6P161
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the mitochondrion-specific ribosomal protein mL54 family.
RefSeq proteins (1): NP_758455* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013870 | Ribosomal_mL54 | Family |
Pfam: PF08561
UniProt features (4 total): transit peptide 1, chain 1, helix 1, turn 1
Structure
Experimental structures (PDB)
78 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 8QU5 | ELECTRON MICROSCOPY | 2.42 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 7PO4 | ELECTRON MICROSCOPY | 2.56 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7O9M | ELECTRON MICROSCOPY | 2.6 |
| 7OF6 | ELECTRON MICROSCOPY | 2.6 |
| 9CN3 | ELECTRON MICROSCOPY | 2.62 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 7OF2 | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | ELECTRON MICROSCOPY | 2.7 |
| 9PR4 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7ODR | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8QSJ | ELECTRON MICROSCOPY | 3 |
| 9UWH | ELECTRON MICROSCOPY | 3 |
| 9PGI | ELECTRON MICROSCOPY | 3.02 |
| 5OOM | ELECTRON MICROSCOPY | 3.03 |
| 8PK0 | ELECTRON MICROSCOPY | 3.03 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P161-F1 | 74.73 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 113 (showing top):
GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, INGRAM_SHH_TARGETS_DN, GOCC_MITOCHONDRIAL_ENVELOPE, ELK1_01, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE, GOCC_RIBOSOMAL_SUBUNIT, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX, chr19p13
GO Biological Process (1): mitochondrial translation (GO:0032543)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial large ribosomal subunit (GO:0005762), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1576 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL54 | MRPL46 | Q9H2W6 | 585 |
| MRPL54 | MRPS22 | P82650 | 578 |
| MRPL54 | MRPL1 | Q9BYD6 | 547 |
| MRPL54 | MRPL52 | Q86TS9 | 536 |
| MRPL54 | RBFA | Q8N0V3 | 496 |
| MRPL54 | MRPL47 | Q9HD33 | 486 |
| MRPL54 | MRPS33 | Q9Y291 | 475 |
| MRPL54 | TNRC18 | O15417 | 474 |
| MRPL54 | MRPL42 | Q9Y6G3 | 474 |
| MRPL54 | MRPL41 | Q8IXM3 | 468 |
| MRPL54 | OSBPL6 | Q9BZF3 | 465 |
| MRPL54 | MRPS18B | Q9Y676 | 449 |
| MRPL54 | MRPL33 | O75394 | 448 |
| MRPL54 | DNPEP | Q9ULA0 | 447 |
| MRPL54 | GALNT18 | Q6P9A2 | 443 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NDUFS3 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.730 |
| MRPL11 | MRPL54 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL54 | MRPL11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPL13 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| NDUFAB1 | MIEF1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| MRPL54 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| Pcna | SIVA1 | psi-mi:“MI:0914”(association) | 0.350 |
| B4galt1 | SLC35B1 | psi-mi:“MI:0914”(association) | 0.350 |
| VPS16 | IPO7 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL50 | MRPL43 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL9 | MRPL43 | psi-mi:“MI:0914”(association) | 0.350 |
| CENPA | ATP5PD | psi-mi:“MI:0914”(association) | 0.350 |
| MKI67 | ARHGAP10 | psi-mi:“MI:0914”(association) | 0.350 |
| psi-mi:“MI:0914”(association) | 0.350 | ||
| MTRES1 | ALDH1L1 | psi-mi:“MI:0914”(association) | 0.350 |
| N | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| LIN28A | MEX3A | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL42 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| NEIL1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPS30 | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL27 | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL53 | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL30 | psi-mi:“MI:0914”(association) | 0.350 | |
| GADD45GIP1 | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL12 | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL12 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL42 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (70): MRPL54 (Co-fractionation), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS), MRPL54 (Affinity Capture-MS)
ESM2 similar proteins: O09111, P0C2B7, P0C2B8, P0C2B9, P25712, P56181, P82649, P82913, P82927, P83565, Q0MQJ0, Q0MQJ1, Q0MQJ2, Q0MQJ3, Q0MQJ4, Q0MQJ5, Q2TBI6, Q3MHJ5, Q3T040, Q5EA71, Q5I0K8, Q5R4S3, Q5R504, Q5TC12, Q5TM62, Q6DDY9, Q6DQX6, Q6P161, Q7Z7F7, Q80X85, Q811I0, Q86TS9, Q8BK30, Q8HXG5, Q99N84, Q9BYC8, Q9CPV3, Q9CPW3, Q9CQ40, Q9CZ83
Diamond homologs: Q1LXI5, Q3MHJ5, Q6P161, Q9CPW3
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL54 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 40 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial ribosome-associated quality control | 18 | 71.3× | 1e-28 |
| Mitochondrial translation initiation | 15 | 61.4× | 1e-22 |
| Mitochondrial translation elongation | 15 | 61.4× | 1e-22 |
| Mitochondrial translation | 13 | 57.7× | 3e-19 |
| Mitochondrial translation termination | 15 | 53.1× | 9e-22 |
| Translation | 13 | 26.0× | 1e-14 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 15 | 74.5× | 3e-23 |
| translation | 8 | 23.5× | 8e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1037962 | NC_000019.9:g.(?3762699)(3808981_?)del | Pathogenic |
SpliceAI
258 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:3762817:AGG:A | donor_loss | 1.0000 |
| 19:3762819:GTGA:G | donor_loss | 1.0000 |
| 19:3765155:C:A | acceptor_gain | 1.0000 |
| 19:3765160:CCCCA:C | acceptor_gain | 1.0000 |
| 19:3765161:CCCA:C | acceptor_gain | 1.0000 |
| 19:3765162:CCA:C | acceptor_gain | 1.0000 |
| 19:3765163:CAG:C | acceptor_gain | 1.0000 |
| 19:3765164:A:AC | acceptor_gain | 1.0000 |
| 19:3765164:A:AG | acceptor_gain | 1.0000 |
| 19:3765165:G:C | acceptor_gain | 1.0000 |
| 19:3765165:G:GC | acceptor_gain | 1.0000 |
| 19:3765165:GT:G | acceptor_gain | 1.0000 |
| 19:3765165:GTT:G | acceptor_gain | 1.0000 |
| 19:3765165:GTTA:G | acceptor_gain | 1.0000 |
| 19:3765165:GTTAT:G | acceptor_gain | 1.0000 |
| 19:3765285:G:GT | donor_gain | 1.0000 |
| 19:3765294:G:GT | donor_gain | 1.0000 |
| 19:3765312:GATGC:G | donor_gain | 1.0000 |
| 19:3765316:C:G | donor_gain | 1.0000 |
| 19:3765327:GAATG:G | donor_gain | 1.0000 |
| 19:3765328:AATG:A | donor_gain | 1.0000 |
| 19:3765329:ATG:A | donor_gain | 1.0000 |
| 19:3765330:TG:T | donor_gain | 1.0000 |
| 19:3765331:GG:G | donor_gain | 1.0000 |
| 19:3765332:G:GG | donor_gain | 1.0000 |
| 19:3765332:G:T | donor_loss | 1.0000 |
| 19:3765333:T:A | donor_loss | 1.0000 |
| 19:3762819:G:GG | donor_gain | 0.9900 |
| 19:3765336:G:GG | donor_gain | 0.9900 |
| 19:3767250:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
887 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:3765330:T:A | W95R | 0.989 |
| 19:3765330:T:C | W95R | 0.989 |
| 19:3765262:C:A | A72D | 0.987 |
| 19:3767265:T:C | F97L | 0.985 |
| 19:3767267:C:A | F97L | 0.985 |
| 19:3767267:C:G | F97L | 0.985 |
| 19:3765321:T:C | Y92H | 0.983 |
| 19:3767341:G:C | R122P | 0.983 |
| 19:3767261:G:C | W95C | 0.982 |
| 19:3767261:G:T | W95C | 0.982 |
| 19:3767359:G:C | R128P | 0.978 |
| 19:3767345:A:C | K123N | 0.977 |
| 19:3767345:A:T | K123N | 0.977 |
| 19:3767332:G:C | R119P | 0.975 |
| 19:3765275:C:A | N76K | 0.972 |
| 19:3765275:C:G | N76K | 0.972 |
| 19:3765267:G:C | G74R | 0.969 |
| 19:3765322:A:C | Y92S | 0.969 |
| 19:3765322:A:G | Y92C | 0.967 |
| 19:3767330:G:C | W118C | 0.966 |
| 19:3767330:G:T | W118C | 0.966 |
| 19:3767338:T:C | L121P | 0.965 |
| 19:3765321:T:G | Y92D | 0.964 |
| 19:3767326:A:C | Y117S | 0.964 |
| 19:3767325:T:C | Y117H | 0.963 |
| 19:3765250:T:C | L68P | 0.960 |
| 19:3765250:T:A | L68H | 0.958 |
| 19:3767368:G:C | R131P | 0.958 |
| 19:3767326:A:G | Y117C | 0.957 |
| 19:3767263:T:A | L96Q | 0.955 |
dbSNP variants (sampled 300 via entrez): RS1000215475 (19:3767032 G>A,C), RS1000501604 (19:3765162 C>A,G,T), RS1000565899 (19:3766782 C>T), RS1000956396 (19:3768017 C>T), RS1001169222 (19:3765553 C>T), RS1001562234 (19:3766482 G>A), RS1001657406 (19:3761753 CG>C), RS1001996028 (19:3761784 G>A,C,T), RS1002707242 (19:3762861 C>G,T), RS1003556815 (19:3764379 G>A,T), RS1003725861 (19:3764232 A>C,G), RS1004337171 (19:3761879 T>C), RS1004562357 (19:3763426 T>C), RS1004673972 (19:3763123 A>C), RS1005228571 (19:3760939 A>C)
Disease associations
OMIM: gene MIM:611858 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007637_40 | Diffusing capacity of carbon monoxide | 6.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009369 | diffusing capacity of the lung for carbon monoxide |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | affects cotreatment, decreases expression | 2 |
| Smoke | increases abundance, increases expression, decreases expression | 2 |
| Cyclosporine | decreases methylation, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| monomethylarsonous acid | decreases expression | 1 |
| abrine | increases expression | 1 |
| bisphenol S | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Cannabidiol | increases expression | 1 |
| Coal | increases expression, increases abundance | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Diuron | decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Selenomethionine | affects expression | 1 |
| Dronabinol | decreases expression | 1 |
| Valproic Acid | decreases expression, increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.